Molecure Statistics

Total Valuation

Molecure has a market cap or net worth of PLN 109.70 million. The enterprise value is 75.74 million.

Market Cap	109.70M
Enterprise Value	75.74M

Important Dates

The next estimated earnings date is Tuesday, September 30, 2025.

Earnings Date	Sep 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Molecure has 20.20 million shares outstanding. The number of shares has increased by 20.05% in one year.

Current Share Class	20.20M
Shares Outstanding	20.20M
Shares Change (YoY)	+20.05%
Shares Change (QoQ)	-33.33%
Owned by Insiders (%)	3.43%
Owned by Institutions (%)	20.00%
Float	14.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	31.45
PB Ratio	1.12
P/TBV Ratio	2.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.56
EV / Sales	21.71
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.60

Financial Position

The company has a current ratio of 10.28, with a Debt / Equity ratio of 0.07.

Current Ratio	10.28
Quick Ratio	10.19
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.23
Interest Coverage	-610.87

Financial Efficiency

Return on equity (ROE) is -30.82% and return on invested capital (ROIC) is -18.60%.

Return on Equity (ROE)	-30.82%
Return on Assets (ROA)	-17.68%
Return on Invested Capital (ROIC)	-18.60%
Return on Capital Employed (ROCE)	-29.58%
Revenue Per Employee	37,110
Profits Per Employee	-315,249
Employee Count	102
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.99% in the last 52 weeks. The beta is 2.36, so Molecure's price volatility has been higher than the market average.

Beta (5Y)	2.36
52-Week Price Change	-58.99%
50-Day Moving Average	7.42
200-Day Moving Average	9.51
Relative Strength Index (RSI)	25.84
Average Volume (20 Days)	49,734

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Molecure had revenue of PLN 3.49 million and -29.63 million in losses. Loss per share was -1.41.

Revenue	3.49M
Gross Profit	170,996
Operating Income	-30.59M
Pretax Income	-29.63M
Net Income	-29.63M
EBITDA	-30.90M
EBIT	-30.59M
Loss Per Share	-1.41

Full Income Statement

Balance Sheet

The company has 40.66 million in cash and 6.69 million in debt, giving a net cash position of 33.97 million or 1.68 per share.

Cash & Cash Equivalents	40.66M
Total Debt	6.69M
Net Cash	33.97M
Net Cash Per Share	1.68
Equity (Book Value)	98.21M
Book Value Per Share	4.86
Working Capital	37.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -28.69 million and capital expenditures -420,981, giving a free cash flow of -29.11 million.

Operating Cash Flow	-28.69M
Capital Expenditures	-420,981
Free Cash Flow	-29.11M
FCF Per Share	-1.44

Full Cash Flow Statement

Margins

Gross Margin	4.90%
Operating Margin	-876.94%
Pretax Margin	-849.49%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Molecure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.05%
Shareholder Yield	n/a
Earnings Yield	-27.01%
FCF Yield	-26.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Molecure has an Altman Z-Score of 11.84 and a Piotroski F-Score of 4.

Altman Z-Score	11.84
Piotroski F-Score	4

Molecure S.A. (WSE:MOC)